Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 75.19M P/E - EPS this Y -6.10% Ern Qtrly Grth -
Income -17.19M Forward P/E -3.33 EPS next Y 60.00% 50D Avg Chg -25.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -63.00%
Recommedations 3.00 Quick Ratio 0.17 Shares Outstanding 68.34M 52W Low Chg 59.00%
Insider Own 12.80% ROA -211.70% Shares Float 61.21M Beta 0.29
Inst Own 6.00% ROE - Shares Shorted/Prior 1.34M/1.07M Price 1.73
Gross Margin - Profit Margin - Avg. Volume 229,796 Target Price 2.50
Oper. Margin - Earnings Date May 13 Volume 85,316 Change -0.57%
About Brainstorm Cell Therapeutics In

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Brainstorm Cell Therapeutics In News
04/16/24 BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
04/11/24 BCLI: Receives SPA Agreement from FDA on Design of Phase 3b Trial of NurOwn™…
04/11/24 BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
04/10/24 BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
04/09/24 BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
04/08/24 BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
04/01/24 BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
03/06/24 BCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS…
02/27/24 BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference
02/23/24 BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS
02/13/24 BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum
12/26/23 BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
12/20/23 BrainStorm Issues 2023 Letter to Shareholders
12/08/23 BCLI: FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwn
12/07/23 BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS
11/20/23 BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
11/17/23 BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia
11/16/23 BCLI: Phase 3b Trial Details to be Discussed with FDA…
11/15/23 Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript
11/15/23 Q3 2023 Brainstorm Cell Therapeutics Inc Earnings Call
BCLI Chatroom

User Image thres Posted - 1 hour ago

$BCLI $SEEL $AMLX $CLNN BCLI remains sole proprietor of Nurown with international patents secured every corner of the earth, any spinal tap clinic can administer most of the treatment anywhere on the face of the earth. Nurown treatment and greater autonomyy vs Long term health care (big time $$$$). It is a no-brainer. A ham sandwich could run this company and hell will break loose any time. Don't sellout, better and bigger times are around the corner whenever that is. ALS patients want Nurown more than anything. No more type 2 errors, no more died waiting, drugs in bodys now!!! Nurown works ask any Nurown ALS patient from EAP or clinical trials. Bobby Forster had to die waiting, it was known 5 years, yes 5 years ago Nurown works!!! Bobby wanted Nurown more than anything and a chance to live, he died waiting because ALSA and FDA totally blocked/obstructed Nurown the whole time. Go Nurown!!! There will be light at the end of this tunnel. https://www.youtube.com/watch?v=jDpvF79JDj4

User Image taryagg Posted - 7 hours ago

$BCLI as I kept saying for a decade. Chaim just can't bring himself to utter some positive news [future promises are worthless; they were never followed up or materialized]. One by one we keep losing the talent that were hired and it's reflected in the SP.

User Image johns83 Posted - 7 hours ago

$BCLI Sellers don’t know what they owned …. News on funding will hit very soon ..

User Image johns83 Posted - 8 hours ago

$BCLI Just waiting for PR .. then focus will be on trial and time horizon to FDA approval which will happen given trial design !

User Image CousinsCapital Posted - 8 hours ago

$BCLI getting slaughtered, we need news bad. A lot of bag holders are going to get stopped out if we get regress back to 30s.

User Image steven_glandsberg Posted - 10 hours ago

$BCLI $BCLI shorts have been trying for days. Bottom was found. This was your last chance to load. Barcode city. Nurown works. No one is here to flip Pennies. Bring your green hat

User Image johns83 Posted - 11 hours ago

$BCLI Sorry CIRM has $4.5 billion in AUM ..

User Image johns83 Posted - 11 hours ago

$BCLI For those not familiar this CA Foundation has been very supportive to funding stem cell for ALS research and BCLI. They have $4.5m in AUM There is capital grants to help the company … https://www.cirm.ca.gov/wp-content/uploads/archive/files/about_cirm/CIRM-Annual%20Report-22_0822_Digital_Page%20Spreads.pdf

User Image PennyConnection1 Posted - 12 hours ago

$BCLI

User Image RollingDollar Posted - 12 hours ago

$BCLI

User Image RollingDollar Posted - 12 hours ago

$BCLI .

User Image chiefmoney Posted - 1 day ago

$BCLI I’ve been here a while and right now most hopeful since Oct 2020. Will be great if we can pull in $20M+ grant alongside large partner. Lock your shares, $25+ limit sell to prevent shorts from accessing and add to your positions if you feel confidence.

User Image Guat69 Posted - 1 day ago

$BCLI can you explain this to me please, are you saying since a reversal this would’ve been the price or this is what it should be?

User Image Megaton Posted - 1 day ago

$BCLI Could it be that we diluted by 25%? Until recently, I calculated the share price according to the value of 1B - and I always got a price of $20 per share. Now shows me 14.5. Did the company use an ATM and are the new shares already on the market?

User Image PennyConnection1 Posted - 1 day ago

$BCLI green finish, hope it builds on from here

User Image johns83 Posted - 1 day ago

$BCLI Interesting Info they should have JV with BCLI https://www.biospace.com/article/amylyx-sheds-more-light-on-relyvrio-s-late-stage-trial-failure-in-als/

User Image Travelling Posted - 1 day ago

$SYTA $alejos11 called this at 48.68 -ugh, I do not think we will see that, but I do think that we could see 5+ , also like $ezgo $smx $ino watching $bcli

User Image PennyConnection1 Posted - 1 day ago

$BCLI it’s been a while that we seen over 10% green

User Image AshvsEvilDead Posted - 1 day ago

$BCLI This.

User Image PennyConnection1 Posted - 1 day ago

$BCLI http://archive.fast-edgar.com/20240417/AIBE9Q2C8Z22TZZZ279Q2ZZZ8TC9Z2X2Z262/

User Image moneymike889 Posted - 1 day ago

$BCLI how do we look at Stacey leaving? She jumping a sinking ship.... Or partnership?

User Image johns83 Posted - 1 day ago

$BCLI For those who have been invested here to the past decade, I was reminded of our Scottish friend Ian who was so articulate and funny. He had ALS and worked tirelessly as has so many others over the past years .. Matt B .. This new trial has the opportunity to be the ONE that helps current and future ALS patients. Their stem cell technology is cutting edge and can cure other diseases like MS and many genetic Ataxia which turns into ALS … They will be the support and funding because to many lives are at stake …

User Image johns83 Posted - 1 day ago

$BCLI My personal take on changes .. after four long years Stacy is exhausted and wants to take a back seat ….It’s that simple

User Image TSLA_S3XY Posted - 1 day ago

$BCLI Company Has No Money To Pay Her, Chaim Treats Her Like Trash. Why Wpulf She Stay? Unfortunately This Companies Best Days Are Behind Them

User Image ALSCellTherapy Posted - 1 day ago

$BCLI

User Image thres Posted - 1 day ago

$BCLI Most of the ALS patients you know on your side of the pond are brainwashed by MNDA and ALSA. That is why the want a pill or an injection. In the US of A, ALS patients want Nurown above all. You get it? They have a fresh mind. At this point, a ham sandwich could run this company and hell will break loose any time. Buy, buy, buy.... Nurown works, go Nurown. Don't sellout, better and bigger times are just around the corner whenever that is. ALS patients want Nurown more than anything. No more type 2 errors, no more died waiting, drugs in bodys now!!! ALS patients demand Nurown!!! Nurown works ask any of Nurown ALS patient from EAP or any clinical trial.

User Image IrishSean Posted - 1 day ago

$BCLI I see Stacys move as a demotion. Hopefully the right move. We can only speculate.

User Image IrishSean Posted - 1 day ago

$BCLI I still feel as a standard of care approach this treatment is very difficult for patients. Most want a pill, injections etc. Not spinal taps and bone marrow extraction but it may be a step in the right direction.

User Image thres Posted - 1 day ago

$BCLI $amlx $clnn $seel The company remains sole proprietor of Nurown with international patents secured every corner of the earth, any spinal tap clinic can administer most of the treatment anywhere on the face of the earth. Nurown treatment and greater autonomyy vs Long term health care (big time $$$$). It is a no-brainer. Buy, buy, buy. Go Nurown, Nurown works.

User Image Knuckles30 Posted - 1 day ago

$BCLI Thres thanks for always liking my post😊

Analyst Ratings
Maxim Group Hold Sep 28, 23
Maxim Group Buy Mar 31, 23
Maxim Group Buy Feb 5, 21
HC Wainwright & Co. Buy May 15, 18
Maxim Group Buy Aug 17, 17